Birdwatch Note
2024-04-22 15:15:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
There's no evidence the drug midazolam was used to kill thousands of COVID patients. There is no evidence that midazolam was being used with the intention of ending care home residents’ lives https://fullfact.org/health/midazolam-video-matt-hancock/
Written by BEE18E9C7A2E77A84F490D1E83D4AD310182F9B3F67BB837A7AE90BEF2475C23
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1782352635980312998
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1782427915822436740
- noteId - 1782427915822436740
- participantId -
- noteAuthorParticipantId - BEE18E9C7A2E77A84F490D1E83D4AD310182F9B3F67BB837A7AE90BEF2475C23 Participant Details
- createdAtMillis - 1713798905699
- tweetId - 1782352635980312998
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- There's no evidence the drug midazolam was used to kill thousands of COVID patients. There is no evidence that midazolam was being used with the intention of ending care home residents’ lives https://fullfact.org/health/midazolam-video-matt-hancock/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-22 15:15:05 UTC (1713798905699) |
2024-04-22 19:03:09 UTC (1713812589881) |
CURRENTLY_RATED_HELPFUL | 2024-04-23 09:11:27 UTC (1713863487030) |
NEEDS_MORE_RATINGS | 2024-04-22 19:03:09 UTC (1713812589881) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-22 20:16:30 -0500 | Rating Details | |
2024-04-22 19:48:15 -0500 | Rating Details | |
2024-04-22 18:42:57 -0500 | Rating Details | |
2024-04-22 17:37:19 -0500 | Rating Details | |
2024-04-22 17:30:31 -0500 | Rating Details | |
2024-04-22 16:50:43 -0500 | Rating Details | |
2024-04-22 16:23:32 -0500 | Rating Details | |
2024-04-22 15:42:25 -0500 | Rating Details | |
2024-04-22 14:25:50 -0500 | Rating Details | |
2024-04-22 14:07:27 -0500 | Rating Details | |
2024-04-22 13:45:26 -0500 | Rating Details | |
2024-04-22 12:49:21 -0500 | Rating Details | |
2024-04-22 10:49:28 -0500 | Rating Details | |
2024-04-23 11:03:38 -0500 | Rating Details | |
2024-04-23 09:07:50 -0500 | Rating Details | |
2024-04-23 06:08:51 -0500 | Rating Details | |
2024-04-23 05:07:16 -0500 | Rating Details | |
2024-04-23 04:13:39 -0500 | Rating Details | |
2024-04-24 14:08:57 -0500 | Rating Details | |
2024-04-25 18:02:44 -0500 | Rating Details | |
2024-04-24 14:24:35 -0500 | Rating Details | |
2024-04-24 09:36:01 -0500 | Rating Details | |
2024-04-23 16:27:11 -0500 | Rating Details | |
2024-04-23 09:19:36 -0500 | Rating Details | |
2024-04-23 06:32:20 -0500 | Rating Details | |
2024-04-23 06:28:23 -0500 | Rating Details | |
2024-04-23 04:29:48 -0500 | Rating Details | |
2024-04-22 20:42:14 -0500 | Rating Details | |
2024-04-22 19:12:02 -0500 | Rating Details | |
2024-04-22 18:19:03 -0500 | Rating Details | |
2024-04-22 18:17:11 -0500 | Rating Details | |
2024-04-22 17:17:41 -0500 | Rating Details | |
2024-04-22 16:34:41 -0500 | Rating Details | |
2024-04-22 15:46:59 -0500 | Rating Details | |
2024-04-22 14:56:33 -0500 | Rating Details | |
2024-04-22 14:54:21 -0500 | Rating Details | |
2024-04-22 14:27:56 -0500 | Rating Details | |
2024-04-22 11:52:17 -0500 | Rating Details | |
2024-04-22 11:19:14 -0500 | Rating Details | |
2024-04-22 11:00:49 -0500 | Rating Details | |
2024-04-22 10:47:11 -0500 | Rating Details | |
2024-04-22 10:41:08 -0500 | Rating Details | |
2024-04-22 10:23:06 -0500 | Rating Details | |
2024-04-22 10:19:05 -0500 | Rating Details | |
2024-04-22 10:17:20 -0500 | Rating Details | |
2024-04-22 15:42:41 -0500 | Rating Details | |
2024-04-25 02:20:38 -0500 | Rating Details | |
2024-04-24 17:43:31 -0500 | Rating Details | |
2024-04-24 06:59:17 -0500 | Rating Details | |
2024-04-23 19:36:55 -0500 | Rating Details | |
2024-04-23 05:07:28 -0500 | Rating Details | |
2024-04-23 04:03:46 -0500 | Rating Details | |
2024-04-22 19:00:48 -0500 | Rating Details | |
2024-04-22 17:10:23 -0500 | Rating Details | |
2024-04-22 17:08:03 -0500 | Rating Details | |
2024-04-22 17:05:55 -0500 | Rating Details | |
2024-04-22 15:52:50 -0500 | Rating Details | |
2024-04-22 15:20:05 -0500 | Rating Details | |
2024-04-22 13:42:23 -0500 | Rating Details | |
2024-04-22 11:27:15 -0500 | Rating Details | |
2024-04-22 10:34:49 -0500 | Rating Details | |
2024-04-22 10:22:57 -0500 | Rating Details | |
2024-04-25 18:41:22 -0500 | Rating Details | |
2024-04-25 06:57:39 -0500 | Rating Details | |
2024-04-24 05:22:23 -0500 | Rating Details | |
2024-04-23 07:35:43 -0500 | Rating Details | |
2024-04-23 07:26:31 -0500 | Rating Details | |
2024-04-23 05:10:50 -0500 | Rating Details | |
2024-04-23 03:56:53 -0500 | Rating Details | |
2024-04-23 01:01:08 -0500 | Rating Details | |
2024-04-22 16:07:38 -0500 | Rating Details | |
2024-04-22 16:05:44 -0500 | Rating Details | |
2024-04-22 15:36:46 -0500 | Rating Details | |
2024-04-22 14:43:45 -0500 | Rating Details | |
2024-04-22 14:25:04 -0500 | Rating Details | |
2024-04-22 13:34:26 -0500 | Rating Details | |
2024-04-22 13:29:27 -0500 | Rating Details | |
2024-04-22 13:25:48 -0500 | Rating Details | |
2024-04-22 11:54:29 -0500 | Rating Details | |
2024-04-22 11:45:11 -0500 | Rating Details | |
2024-04-22 11:24:07 -0500 | Rating Details | |
2024-04-22 10:55:02 -0500 | Rating Details | |
2024-04-22 10:41:29 -0500 | Rating Details |